Mouse models of diabetic retinopathy: Systematic review of the literature;Revue systématique de la littérature des modèles murins de rétinopathie diabétique

Journal Francais d'Ophtalmologie

Volumn 36, Issue 3, 2013, Pages 268-276

  Giocanti Auregan, A ^a,b   Tadayoni, R ^c   Ahn, L ^a   Pena, J T ^a   D'Amico, D J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Animal model; Diabetes; Diabetic retinopathy; Mouse; Retina

Indexed keywords

GALACTOSE; INSULIN;

ANIMAL; BLOOD; BLOOD RETINA BARRIER; DIABETIC RETINOPATHY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; ISCHEMIA; MALE; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; REVIEW; VITREOUS HEMORRHAGE;

ANIMALS; BLOOD GLUCOSE; BLOOD-RETINAL BARRIER; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FEMALE; GALACTOSE; INSULIN; ISCHEMIA; MALE; MICE; MICE, INBRED NOD; MICE, MUTANT STRAINS; MICE, OBESE; PERICYTES; RETINAL DETACHMENT; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; VITREOUS HEMORRHAGE;

EID: 84875213470     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2012.08.001     Document Type: Review

References (47)

1. L.P. Aiello, T.W. Gardner, G.L. King, G. Blankenship, J.D. Cavallerano, and F.L. Ferris 3rd. Diabetic retinopathy Diabetes Care 21 1998 143 156
2. Early Treatment Diabetic Retinopathy Study research Group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol. 103 1985 1796 1806
3. Early Treatment Diabetic Retinopathy Research Group Early photocoagulation for diabetic retinopathy ETDRS report number 9 Ophthalmology 98 1991 766 785
4. The Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy, the second report of Diabetic Retinopathy Study findings Ophthalmology 85 1978 82 106
5. The Diabetic Retinopathy Study Research Group Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study report number 14 Int Ophthalmol Clin 27 1987 239 253
6. Early Treatment Diabetic Retinopathy Research Group Photocoagulation for diabetic macular edema. ETDRS report number 1 Arch Ophthalmol 103 1985 1796 1806
7. C.P. Wilkinson, F.L. Ferris 3rd., R.E. Klein, P.P. Lee, and C.D. Agardh Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology 110 2003 1677 1682
8. British Multicenter study Group Photocoagulation for diabetic maculopathy. A randomized controlled clinical trial using the xenon arc Diabetes 32 1983 1010 1016
9. Q.D. Nguyen, S.M. Shah, A.A. Khwaja, R. Channa, E. Hatef, and D.V. Do READ-2 Study Group. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
10. Q.D. Nguyen, S.M. Shah, J.S. Heier, D.V. Do, J. Lim, and D. Boyer READ-2 Study Group. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the macula in diabetes (READ-2) study Group Ophthalmology 116 11 2009 2175 2181
11. P. Massin, F. Bandello, J.G. Garweg, L.L. Hansen, S.P. Harding, and M. Larsen Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study Diabetes Care 33 11 2010 2399 2405
12. o 3 Ophthalmology 95 1988 1307 1320
13. A.M. Joussen, and S. Joeres Benefits and limitations in vitreoretinal surgery for proliferative diabetic retinopathy and macular edema Dev Ophthalmol 39 2007 69 87
14. A. Martidis, J.S. Duker, P.B. Greenberg, A.H. Rogers, C.A. Puliafito, and E. Reichel Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology 109 2002 920 927
15. P. Massin, F. Audren, B. Haouchine, A. Erginay, J.F. Bergmann, and R. Benosman Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial Ophthalmology 111 2004 218 224
16. F. Audren, A. Erginay, B. Haouchine, R. Benosman, J. Conrath, and J.F. Bergmann Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: 6-month results of a prospective controlled trial Acta Ophthalmol Scand 84 2006 624 630
17. J.B. Jonas, B.A. Kamppeter, B. Harder, U. Vossmerbaeumer, G. Sauder, and U.H. Spandau Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study J Ocul Pharmacol Ther 22 2006 200 207
18. M.C. Gillies, F.M. Islam, M. Zhu, J. Larsson, and T.Y. Wong Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema Br J Ophthalmol 91 2007 1323 1326
19. R.L. Engerman, and T.S. Kern Retinopathy in animal models of diabetes Diabetes Metab Rev 11 1995 109 120
20. D.Y. Yu, S.J. Cringle, E.N. Su, P.K. Yu, G. Jerums, and M.E. Cooper Pathogenesis and intervention strategies in diabetic retinopathy Clin Exp Ophthalmol 29 2001 164 166
21. R.L. Engerman Pathogenesis of diabetic retinopathy Diabetes. 38 1989 1203 1206
22. R.A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, and T.S. Kern Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes Invest Ophthalmol Vis Sci 46 2005 4281 4287
23. P.M. Martin, P. Roon, T.K. Van Ells, V. Ganapathy, and S.B. Smith Death of retinal neurons in streptozotocin-induced diabetic mice Invest Ophthalmol Vis Sci 45 2004 3330 3336
24. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol Res 50 2001 537 546
25. S.G. Shaw, J.P. Boden, E. Biecker, J. Reichen, and B. Rothen Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin Exp Biol Med (Maywood) 231 2006 1101 1105
26. M.S. Anderson, and J.A. Bluestone The NOD mouse: a model of immune dysregulation Ann Rev Immunol 23 2005 447 485
27. R.J. Chaparro, and T.P. Dilorenzo An update on the use of NOD mice to study autoimmune (Type 1) diabetes Expert Rev Clin Immunol 6 2010 939 955
28. A.K. Cheung, M.K. Fung, A.C. Lo, T.T. Lam, K.F. So, and S.S. Chung Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice Diabetes 54 2005 3119 3125
29. R. Tadayoni, M. Paques, A. Gaudric, and E. Vicaut Erythrocyte and leukocyte dynamics in the retinal capillaries of diabetic mice Exp Eye Res 77 2003 497 504
30. H. Kodama, M. Fujita, and I. Yamaguchi Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice Diabetologia 37 1994 739 744
31. E. Midena, T. Segato, S. Radin, G. di Giorgio, F. Meneghini, and S. Piermarocchi Studies on the retina of the diabetic db/db mouse I. Endothelial cell-pericyte ratio Ophthalmic Res 21 1989 106 111
32. E. Suganami, H. Takagi, H. Ohashi, K. Suzuma, I. Suzuma, and H. Oh Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells Diabetes 53 2004 2443 2448
33. X. Ning, Q. Baoyu, L. Yuzhen, S. Shuli, E. Reed, and Q.Q. Li Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina Int J Mol Med 13 2004 87 92
34. J. Duhault, F. Lebon, and M. Boulanger KK mice as a model of microangiopathic lesions in diabetes Bibl Anat 11 1973 453 458
35. E.P. Rakoczy, I.S. Ali Rahman, N. Binz, C.R. Li, N.N. Vagaja, and M. de Pinho Characterization of a mouse model of hyperglycemia and retinal neovascularization Am J Pathol 177 2010 2659 2670
36. W.S. Wright, A. Singh Yadav, R.M. McElhatten, and N.R. Harris Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse Exp Eye Res 98 2012 9 15
37. F. Pfister, Y. Feng, F. vom Hagen, S. Hoffmann, G. Molema, and J.L. Hillebrands Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy Diabetes 57 2008 2495 2502
38. A.J. Barber, D.A. Antonetti, T.S. Kern, C.E. Reiter, R.S. Soans, and J.K. Krady The Ins2Akita mouse as a model of early retinal complications in diabetes Invest Ophthalmol Vis Sci 46 2005 2210 2218
39. T.S. Kern, and R.L. Engerman A mouse model of diabetic retinopathy Arch Ophthalmol 114 1996 986 990
40. T.S. Kern, J. Tang, and B.A. Berkowitz Validation of structural and functional lesions of diabetic retinopathy in mice Mol Vis 16 2010 2121 2131 Review
41. E.C. Leal, A. Manivannan, K. Hosoya, T. Terasaki, J. Cunha-Vaz, and A.F. Ambrósio Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy Invest Ophthalmol Vis Sci 48 2007 5257 5265
42. R.F. Gariano, A.K. Nath, D.J. D'Amico, T. Lee, and M.R. Sierra-Honigmann Elevation of vitreous leptin in diabetic retinopathy and retinal detachment Invest Ophthalmol Vis Sci 41 2000 3576 3581
43. D. Gaucher, J.A. Chiappore, M. Pâques, M. Simonutti, C. Boitard, and J.A. Sahel Microglial changes occur without neural cell death in diabetic retinopathy Vision Res 47 2007 612 623
44. R.A. Cuthbertson, and T.E. Mandel The effect of murine fetal islet transplants on renal and retinal capillary basement membrane thickness Transplant Proc 19 1987 2919 2921
45. R.S. Clements Jr., W.G. Robison Jr., and M.P. Cohen Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice J Diabetes Complications 12 1998 28 33
46. G.R. Barile, S.I. Pachydaki, S.R. Tari, S.E. Lee, C.M. Donmoyer, and W. Ma The RAGE axis in early diabetic retinopathy Invest Ophthalmol Vis Sci 46 2005 2916 2924
47. G.T. Chong, S. Farsiu, S.F. Freedman, N. Sarin, A.F. Koreishi, and J.A. Izatt Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography Arch Ophthalmol 127 2009 37 44